[1] Y. Sakr, J. L. Vincent, K. Reinhart et al., “High tidal volume and positive fluid balance are associated with worse outcome in acute lung injury,” Chest, vol. 128, no. 5, pp. 3098–3108, 2005.
[2] R. S. Simmons, G. G. Berdine, J. J. Seidenfeld et al., “Fluid balance and the adult respiratory distress syndrome,” American Review of Respiratory Disease, vol. 135, no. 4, pp. 924–929, 1987.
[3] A. L. Rosenberg, R. E. Dechert, P. K. Park, R. H. Bartlett, and N. N. A. Network, “Review of a large clinical series: association of cumulative fluid balance on outcome in acute lung injury: a retrospective review of the ARDSnet tidal volume study cohort,” Journal of Intensive Care Medicine, vol. 24, no. 1, pp. 35–46, 2009.
[4] C. V. Murphy, G. E. Schramm, J. A. Doherty et al., “The impor- tance of fluid management in acute lung injury secondary to septic shock,” Chest, vol. 136, no. 1, pp. 102–109, 2009.
[5] S. G. Sakka, M. Klein, K. Reinhart, and A. Meier-Hellmann, “Prognostic value of extravascular lung water in critically III patients,” Chest, vol. 122, no. 6, pp. 2080–2086, 2002.
[6] J. P. Mitchell, D. Schuller, F. S. Calandrino, and D. P. Schuster, “Improved outcome based on fluid management in critically ill patients requiring pulmonary artery catheterization,” American Review of Respiratory Disease, vol. 145, no. 5, pp. 990–998, 1992.
[7] D. Schuller, J. P. Mitchell, F. S. Calandrino, and D. P. Schuster, “Fluid balance during pulmonary edema: is fluid gain a marker or a cause of poor outcome?” Chest, vol. 100, no. 4, pp. 1068–1075, 1991.
[8] H. P. Wiedemann, A. P. Wheeler et al., “Comparison of two fluid-management strategies in acute lung injury,” The New England Journal of Medicine, vol. 354, no. 24, pp. 2564–2575, 2006.
[9] A. G. Randolph, P. W. Forbes, R. G. Gedeit et al., “Cumulative fluid intake minus output is not associated with ventilator weaning duration or extubation outcomes in children,” Pediatric Critical Care Medicine, vol. 6, no. 6, pp. 642–647, 2005.
[10] H. R. Flori, D. V. Glidden, G. W. Rutherford, and M. A. Matthay, “Pediatric acute lung injury: prospective evaluation of risk factors associated with mortality,” American Journal of Respiratory and Critical Care Medicine, vol. 171, no. 9, pp. 995– 1001, 2005.
[11] G. R. Bernard, A. Artigas, K. L. Brigham et al., “The North American-European consensus conference on ARDS,” American Journal of Respiratory and Critical Care Medicine, vol. 149, no. 3, pp. 818–824, 1994.
[12] H. R. Flori, L. B. Ware, D. Glidden, and M. A. Matthay, “Early elevation of plasma soluble intercellular adhesion molecule-1 in pediatric acute lung injury identifies patients at increased risk of death and prolonged mechanical ventilation,” Pediatric Critical Care Medicine, vol. 4, no. 3, pp. 315–321, 2003.
[13] H. R. Flori, L. B. Ware, M. Milet, and M. A. Matthay, “Early elevation of plasma von Willebrand factor antigen in pediatric acute lung injury is associated with an increased risk of death and prolonged mechanical ventilation,” Pediatric Critical Care Medicine, vol. 8, no. 2, pp. 96–101, 2007.
[14] A. M. LeVine, A. Lotze, S. Stanley et al., “Surfactant content in children with inflammatory lung disease,” Critical Care Medicine, vol. 24, no. 6, pp. 1062–1067, 1996.
[15] B. Jacobs and V. N. Bal, “Cytokines in children with ARDS,” Critical Care Medicine, vol. 33, article A43, 2006.
[16] M. Santschi, P. Jouvet, F. Leclerc et al., “Acute lung injury in children: therapeutic practice and feasibility of international clinical trials,” Pediatric Critical Care Medicine, vol. 11, no. 6, pp. 681–689, 2010.
[17] M. M. Pollack, K. M. Patel, and U. E. Ruttimann, “PRISM III: an updated pediatric risk of mortality score,” Critical Care Medicine, vol. 24, no. 5, pp. 743–752, 1996.